Clinical Trial Update: Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated lenalidomide in older patients with acute myeloid leukemia without chromosome 5q abnormalities and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Myeloid, Acute | Phase 2 | Status: COMPLETED | Results posted: 2014-09-29